课题基金 / 基金详情

CLINICAL TRIAL: ETANERCEPT IN DERMATOMYOSITIS

CLINICAL TRIAL: ETANERCEPT IN DERMATOMYOSITIS
临床试验：依那西普治疗皮肌炎
批准号：
7951201
负责人：
Richard J. Barohn
金额：
$1.82万
依托单位：
UNIVERSITY OF KANSAS MEDICAL CENTER
依托单位国家：
美国
项目类别：
财政年份：
2009
资助国家：
美国
项目状态：
已结题
起止时间：
2009-04-01 至 2010-03-31
来源：
https://reporter.nih.gov/project-details/7951201
关键词：
AffectClinical ResearchClinical TrialsComputer Retrieval of Information on Scientific Projects DatabaseDermatomyositisEtanerceptFundingGrantInstitutionMusclePatientsPharmaceutical PreparationsPrednisoneResearchResearch PersonnelResourcesSafetySourceUnited States National Institutes of Health

项目摘要

项目成果

Richard J. Barohn的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The purpose of this study is to determine the safety and tolerability of a medication known as etanercept in patients with DM. Also to see how etanercept and prednisone affect the strength and function of your muscles.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Frontiers: University of Kansas Clinical and Translational Science Institute
Frontiers: University of Kansas Clinical and Translational Science Institute
Models of Neuromuscular Disease Across the Lifespan
A Phase II Trial of Rituximab In Myasthenia Gravis
  • 批准号：
    8644497
  • 项目类别：
  • 资助金额：
    $130.54万
  • 财政年份：
    2013
  • 负责人：
    Richard J. Barohn
  • 依托单位：
    YALE UNIVERSITY
海外基金